Luay Susan, MD
Urology · Cleveland, OHNPI 1063479772
Payments from drug & device makers
Across 49 payments — averaging $61.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$571
- Laborie Medical Technologies Corp.$422
- Johnson & Johnson$393
- 180 Medical, Inc.$171
- Medtronic$152
- AbbVie$142
- plus $1K from 11 others
What the payments were for
- Food & beverage$2,87196%
- Education$1284%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 15 | $571 |
| Laborie Medical Technologies Corp. | 4 | $422 |
| Johnson & Johnson(2 entities) | 7 | $393 |
| 180 Medical, Inc. | 1 | $171 |
| Medtronic | 2 | $152 |
| AbbVie | 3 | $142 |
| Janssen Scientific Affairs, LLC | 1 | $136 |
| Endo Pharmaceuticals Inc. | 2 | $135 |
| Blue Earth Diagnostics | 2 | $132 |
| Teleflex LLC | 2 | $132 |
| Procept Biorobotics Corporation | 1 | $128 |
| Inspire Medical Systems, Inc. | 1 | $127 |
| Urogen Pharma, Inc. | 4 | $120 |
| Tempus AI, Inc | 1 | $113 |
| Boston Scientific | 1 | $88 |
| Convatec Inc. | 1 | $21 |
| Endo USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iTIND System$430
- Erleada$260
- Cure Catheter$171
- AKEEGA$136
- AQUABEAM SYSTEM$128
- Inspire$127
- RYBREVANT$121
- CARVYKTI$121
- POSLUMA$119
- EndoSheath Technology$118
- XIAFLEX$116
- UroLift$114
How this compares
$3,000 in reported general payments places this provider in the 50th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 40 | $25,729 |
| Tamsulosin Hcl | 470 | $5,923 |
| Oxybutynin Chloride ErOxybutynin Chloride | 199 | $4,560 |
| Finasteride | 254 | $2,876 |
| Trospium Chloride | 27 | $2,083 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 81 | $1,594 |
| Cephalexin | 178 | $854 |
| Ciprofloxacin Hcl | 128 | $655 |
| Dutasteride | 12 | $453 |
| Bicalutamide | 14 | $347 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 34 | $327 |
| Solifenacin Succinate | 12 | $253 |
| Ketorolac Tromethamine | 12 | $168 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $112 |
| Tramadol Hcl | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other urology in Cleveland
- Howard GoldmanCleveland$747K
- Jihad KaoukCleveland$696K
- Raymond RackleyCleveland$695K
- Sandip VasavadaCleveland$512K
- Petar BajicCleveland$321K
- Sriharan SivalingamCleveland$282K
- Adonis HijazCleveland$263K
- Ruben OlivaresCleveland$184K
- Ahmed AboumohamedCleveland$139K
- Jorge Gutierrez AcevesCleveland$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.